Teladoc, Inc. (NYSE:TDOC) announced its quarterly earnings data on Wednesday. The health services provider reported ($0.55) EPS for the quarter, missing the consensus estimate of ($0.30) by ($0.25), Briefing.com reports. The firm had revenue of $68.70 million for the quarter, compared to analysts’ expectations of $67.53 million. Teladoc had a negative net margin of 47.75% and a negative return on equity of 19.88%. The business’s quarterly revenue was up 112.0% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.33) EPS.

Several equities analysts have commented on the company. Robert W. Baird lowered Teladoc from an “outperform” rating to a “neutral” rating and raised their price objective for the company from $14.00 to $36.00 in a research report on Monday, September 18th. KeyCorp reissued a “buy” rating and set a $37.00 price objective on shares of Teladoc in a research report on Sunday, September 17th. Zacks Investment Research lowered Teladoc from a “hold” rating to a “sell” rating in a research report on Monday, July 17th. Piper Jaffray Companies reissued a “buy” rating and set a $32.00 price objective on shares of Teladoc in a research report on Friday, July 14th. Finally, BidaskClub lowered Teladoc from a “buy” rating to a “hold” rating in a research report on Tuesday, July 25th. Five analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $38.00.

COPYRIGHT VIOLATION NOTICE: “Teladoc, Inc. (TDOC) Issues Quarterly Earnings Results” was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://www.americanbankingnews.com/2017/11/02/teladoc-inc-tdoc-issues-quarterly-earnings-results.html.

In related news, insider Adam C. Vandervoort sold 53,806 shares of the company’s stock in a transaction on Monday, August 7th. The stock was sold at an average price of $30.92, for a total transaction of $1,663,681.52. Following the completion of the sale, the insider now directly owns 33,008 shares in the company, valued at approximately $1,020,607.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Mark Hirschhorn sold 10,000 shares of the company’s stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $34.04, for a total value of $340,400.00. The disclosure for this sale can be found here. Insiders have sold a total of 168,806 shares of company stock valued at $5,430,382 over the last 90 days. 4.47% of the stock is currently owned by company insiders.

Teladoc Company Profile

Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

Earnings History for Teladoc (NYSE:TDOC)

Receive News & Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related companies with MarketBeat.com's FREE daily email newsletter.